Abstract
This study investigates a novel synthetic pathway for N-substituted polycyclic heterocycles with potential antileukemic activity. The strategy employs Morita–Baylis–Hillman (MBH) adducts derived from polycyclic 1,2-diketones such as acenaphthoquinone and phenanthrene-9,10-dione. The key steps involve acetylation of the MBH adducts followed by cyclization with primary amines to afford N-heterocycles, specifically acenaphtho[1,2-b]pyrroles and dibenzo[e,g]indoles. The synthesized compounds were evaluated in vitro against leukemia cell lines (Jurkat and NB4). Several derivatives exhibited promising activity, with compound 4b showing particularly strong potency against the NB4 cell line. Overall, this work advances the development of novel antileukemic agents and underscores the potential of N-substituted polycyclic heterocycles in leukemia therapy.
Funding Information
  • Fundo de Apoio ao Ensino, à Pesquisa e Extensão, Universidade Estadual de Campinas
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (306142/2022-8)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (407960/2023-6)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/07600-3)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2023/09724-3)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2023/18007-3)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)

This publication has 64 references indexed in Scilit: